Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Alkaline Sphingomyelinase Assay Kit (ab241039)

Alkaline Sphingomyelinase Assay Kit (ab241039)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Detection method: Colorimetric

You may also be interested in

Anti-Mer2 (phospho S30) antibody (ab47254)
Product image
Recombinant Human MUM1 protein (ab132104)
Wnt2/IRP peptide (ab197186)
Product image
Anti-Niemann Pick C2 antibody (ab186829)

Overview

  • Product name

    Alkaline Sphingomyelinase Assay Kit
    See all Acid sphingomyelinase kits
  • Detection method

    Colorimetric
  • Product overview

    Alkaline Sphingomyelinase (AlkSMase) Assay Kit (ab241039) provides a simple, high throughput adaptable means to identify and quantify alkaline sphingomyelinase activity in a variety of samples without influence from neutral or acid sphingomyelinase.  Upon incubation with substrate, the hydrolysis produces an intermediate that reacts with the probe, generating a colorimetric signal.


    The assay can detect as low as 0.5 µU of alkaline sphingomyelinase activity.

Properties

  • Storage instructions

    Store at -20°C. Please refer to protocols.
  • Components Identifier 100 tests
    AlkSMase Assay Buffer WM 1 x 25ml
    AlkSMase Developer Buffer NM 1 x 5ml
    AlkSMase Enzyme Mix I (Lyophilized) Green 1 vial
    AlkSMase Enzyme Mix II (Lyophilized) White 1 vial
    AlkSMase Positive Control (Lyophilized) Orange 1 vial
    AlkSMase Probe (in DMSO) Red 1 x 200µl
    AlkSMase Substrate (Lyophilized) Blue 1 vial
    Choline Standard (Lyophilized) Yellow 1 vial
  • Research areas

    • Cell Biology
    • Apoptosis
    • Intracellular
    • Associated Proteins
    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Other
    • Signal Transduction
    • Metabolism
    • Lipid metabolism
    • Kits/ Lysates/ Other
    • Kits
    • Cell Metabolism Kits
    • Lipid Metabolism Kits
    • Lipid metabolism
    • Metabolism
    • Types of disease
    • Cancer
  • Function

    Converts sphingomyelin to ceramide. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol. Isoform 2 and isoform 3 have lost catalytic activity.
  • Involvement in disease

    Defects in SMPD1 are the cause of Niemann-Pick disease type A (NPDA) [MIM:257200]; also known as Niemann-Pick disease classical infantile form. It is an early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, mental retardation, digestive disorders, failure to thrive, major hepatosplenomegaly, and severe neurologic symptoms. The severe neurological disorders and pulmonary infections lead to an early death, often around the age of four. Clinical features are variable. A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B.
    Defects in SMPD1 are the cause of Niemann-Pick disease type B (NPDB) [MIM:607616]; also known as Niemann-Pick disease visceral form. It is a late-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Clinical signs involve only visceral organs. The most constant sign is hepatosplenomegaly which can be associated with pulmonary symptoms. Patients remain free of neurologic manifestations. However, a phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B. In Niemann-Pick disease type B, onset of the first symptoms occurs in early childhood and patients can survive into adulthood.
  • Sequence similarities

    Belongs to the acid sphingomyelinase family.
    Contains 1 saposin B-type domain.
  • Cellular localization

    Lysosome.
  • Target information above from: UniProt accession P17405 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Alternative names

    • Acid sphingomyelinase
    • ASM
    • ASM_HUMAN
    • aSMase
    • NPD
    • Smpd1
    • Sphingomyelin phosphodiesterase
    • Sphingomyelin phosphodiesterase 1 acid lysosomal
    see all

Images

  • Choline standard curve.
    Choline standard curve.
    Choline standard curve.
  • Alkaline Sphingomyelinase activity of NPP7.
    Alkaline Sphingomyelinase activity of NPP7.
    Alkaline Sphingomyelinase activity of NPP7. Hydrolysis was allowed to proceed for 1 hr. Neutral Sphingomyelinase (nSMase, purple bar) showed minimal activity after the same incubation time.
  • Activity determination of intestinal tissue lysate.
    Activity determination of intestinal tissue lysate.

    Activity determination of intestinal tissue lysate. For this experiment, 100 mg rat intestine was used, following Alkaline Sphingomyelinase Activity Assay Kit protocol with 2X protease inhibitor. Lysate was assayed and specific activity was determined to be 0.016 nmol/min/µg lysate.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Alkaline Sphingomyelinase Assay Kit (ab241039)

  •  
  • Product image

    Acidic Sphingomyelinase Assay Kit (Fluorimetric) (ab190554)

    Applications:

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Prosurfactant Protein C antibody [EPR19839] (ab211326)

  •  
  • Product image

    Anti-MCM2 (phospho S27) antibody [EPR4119] (ab109459)

  •  
  • Product image

    Anti-15 Lipoxygenase 1 antibody [EPR22136] (ab242062)

  •  
  • Product image

    Anti-Tau (phospho T181) antibody [EPR23506-107] - BSA and Azide free (ab277644)

  •  
  • Product image

    Anti-Histone H3 (di methyl K23) antibody [RM171] (ab214654)

  •  
  • Product image

    Anti-Cytochrome P450 2B6/CYP2B6 antibody [EPR9985(B)] (ab140609)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.